IDDF2021-ABS-0040 Less liver fibrosis marker increment in overweight chronic hepatitis b patients ob...
IDDF2021-ABS-0040 Less liver fibrosis marker increment in overweight chronic hepatitis b patients observed by age-adjusted fibrosis-4 index
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundChronic hepatitis B patients in Taiwan with no or limited liver injury are not reimbursed for antiviral treatment by the Taiwan National Health Insurance (NHI). Innovative fibrosis marker, age-adjusted Fibrosis-4 Index (FIB4-AA), was implemented to evaluate the tendency of liver fibrosis in these patients.MethodsThe FIB-4 indices of 256 a...
Alternative Titles
Full title
IDDF2021-ABS-0040 Less liver fibrosis marker increment in overweight chronic hepatitis b patients observed by age-adjusted fibrosis-4 index
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2568457149
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2568457149
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2021-IDDF.68
